UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$155M |
| 2 |
Wells Fargo
WFC
|
+$134M |
| 3 |
Biogen
BIIB
|
+$121M |
| 4 |
Alibaba
BABA
|
+$108M |
| 5 |
Delta Air Lines
DAL
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$255M |
| 2 |
Chevron
CVX
|
+$220M |
| 3 |
Bank of Montreal
BMO
|
+$192M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$191M |
| 5 |
Enbridge
ENB
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Atara Biotherapeutics
ATRA
$76.1M
| $8.99M | 0.01% |
8,697
-609
| -7% | -$595K |
|
927
National Health Investors
NHI
$3.65B
| $8.95M | 0.01% |
118,425
+4,300
| +4% | +$328K |
|
928
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $8.94M | 0.01% |
102,691
-6,627
| -6% | -$573K |
|
929
Supernus Pharmaceuticals
SUPN
$2.77B
| $8.92M | 0.01% |
177,171
+7,787
| +5% | +$385K |
|
930
RPM International
RPM
$15B
| $8.9M | 0.01% |
137,122
+714
| +0.5% | +$46K |
|
931
Compañía de Minas Buenaventura
BVN
$8.67B
| $8.86M | 0.01% |
660,647
+22,246
| +3% | +$289K |
|
932
Teledyne Technologies
TDY
$32B
| $8.84M | 0.01% |
35,828
+717
| +2% | +$163K |
|
933
Tyler Technologies
TYL
$12.8B
| $8.82M | 0.01% |
35,971
+1,352
| +4% | +$322K |
|
934
Murphy Oil
MUR
$4.78B
| $8.75M | 0.01% |
262,436
-75,300
| -22% | -$2.39M |
|
935
Regenxbio
RGNX
$708M
| $8.74M | 0.01% |
115,751
+103,628
| +855% | +$7.47M |
|
|
PTLA
936
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $8.71M | 0.01% |
327,180
-11,610
| -3% | -$379K |
|
|
VVC
937
DELISTED
Vectren Corporation
VVC
| $8.56M | 0.01% |
119,753
+7,681
| +7% | +$548K |
|
938
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
| $8.42M | 0.01% |
290,776
-33,942
| -10% | -$1M |
|
939
Factset
FDS
$10.2B
| $8.39M | 0.01% |
37,504
+1,366
| +4% | +$296K |
|
|
TMX
940
DELISTED
Terminix Global Holdings, Inc.
TMX
| $8.36M | 0.01% |
201,125
+7,692
| +4% | +$308K |
|
941
iShare MSCI Eurozone ETF
EZU
$9.91B
| $8.33M | 0.01% |
203,127
-544,675
| -73% | -$22.6M |
|
|
MDCO
942
DELISTED
Medicines Co
MDCO
| $8.32M | 0.01% |
278,270
-287,306
| -51% | -$10.8M |
|
943
Reliance Steel & Aluminium
RS
$21.6B
| $8.3M | 0.01% |
97,352
+565
| +0.6% | +$50K |
|
|
XHR
944
Xenia Hotels & Resorts
XHR
$1.79B
| $8.3M | 0.01% |
350,013
+26,048
| +8% | +$629K |
|
945
Herbalife
HLF
$1.29B
| $8.29M | 0.01% |
151,985
+385
| +0.3% | +$21.3K |
|
946
Allison Transmission
ALSN
$9.82B
| $8.19M | 0.01% |
157,504
-101,811
| -39% | -$4.78M |
|
947
Prudential
PUK
$35.2B
| $8.19M | 0.01% |
183,990
+8,689
| +5% | +$384K |
|
|
TLND
948
DELISTED
Talend S.A. American Depositary Shares
TLND
| $8.12M | 0.01% |
116,500
+3,800
| +3% | +$239K |
|
949
SITE Centers
SITC
$165M
| $8.07M | 0.01% |
772,480
-166,447
| -18% | -$1.81M |
|
950
STAG Industrial
STAG
$7.19B
| $8.07M | 0.01% |
293,448
+32,026
| +12% | +$892K |
|
Similar funds
UBS AM's Q3 2018 Portfolio in Review
As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
- UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
- UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
- UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
- UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
- UBS AM opened 86 new positions and closed 106 in Q3 2018.
- UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.